Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
By incorporating miRNA structures into gene therapy agents, it aims to inhibit the production of the mutant Z-AAT protein and promote the production of functional A1AT (79)
Its a hyaluronic acid serum containing hydrolyzed hyaluronic acid, with a mix of other humectants, antioxidants, emollients and skin conditioning agents
10.1016/j.ejphar.2005.12.087 Eur
A1AT inhibits a variety of serine proteinases, but its main target is represented by Neutrophil Elastase (NE)
2002;283:E65866
Microchem J 184:108191 Hossain MS, Jahan S, Rahman SA, Rahman M, Kumar D, Paul S, Rajbangshi JC (2023) Design expert software assisted development and evaluation of empagliflozin and sitagliptin combination tablet with improved in-vivo anti-diabetic activities
US$ 28.67
US$ 29.00
US$ 27.35
